Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-10-17

Clinical Trial Update: The Effect of Valproate on Benzodiazepine Withdrawal Severity [NA]

View source ↗

Summary

A completed clinical trial evaluating whether valproate affects benzodiazepine withdrawal severity in individuals with substance withdrawal syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valproate (valproate)

Snippet

Sponsor: University of Helsinki | Conditions: Substance Withdrawal Syndrome | NA | Status: COMPLETED